Co-Authors
This is a "connection" page, showing publications co-authored by Juan Ambrosioni and Montse Tuset.
Connection Strength
0.175
-
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother. 2021 11 12; 76(12):3296-3302.
Score: 0.061
-
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection. Rev Esp Quimioter. 2021 Jun; 34(3):238-244.
Score: 0.059
-
COVID-19: from epidemiology to treatment. Eur Heart J. 2020 06 07; 41(22):2092-2112.
Score: 0.055